Question, MGK_2: I understand the advantages of partnering with a BP for NASH, and you mention Madrigal, the owner of Resmetirom. But since we only used LL for our 700 mg trial - and if the results ARE really good - why would pair our drug with something else . . . .that might (possibly) dilute the effectiveness of LL?

Just don't want us to risk our (hopefully) "proven" success with liver disease by teaming up with a drug that might possibly compromise our results.